CN102626443A - 治疗痛风中草药组合物 - Google Patents
治疗痛风中草药组合物 Download PDFInfo
- Publication number
- CN102626443A CN102626443A CN2012101208366A CN201210120836A CN102626443A CN 102626443 A CN102626443 A CN 102626443A CN 2012101208366 A CN2012101208366 A CN 2012101208366A CN 201210120836 A CN201210120836 A CN 201210120836A CN 102626443 A CN102626443 A CN 102626443A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese
- gram
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 29
- 241000411851 herbal medicine Species 0.000 title abstract description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 6
- 241000283690 Bos taurus Species 0.000 claims description 5
- 239000008361 herbal raw material Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 21
- 239000002994 raw material Substances 0.000 abstract description 5
- 240000000031 Achyranthes bidentata Species 0.000 abstract 1
- 241000759271 Alangium Species 0.000 abstract 1
- 241000167549 Aralia chinensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000917739 Cinnamomum wilsonii Species 0.000 abstract 1
- 241000058073 Cynanchum mooreanum Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 240000005779 Jasminum multiflorum Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 240000003152 Rhus chinensis Species 0.000 abstract 1
- 235000014220 Rhus chinensis Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 26
- 210000000582 semen Anatomy 0.000 description 9
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 241000903946 Clematidis Species 0.000 description 3
- 239000008589 Cortex Fraxini Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000001773 anti-convulsant effect Effects 0.000 description 3
- 229940117916 cinnamic aldehyde Drugs 0.000 description 3
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010018634 Gouty Arthritis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 244000056623 Iphigenia indica Species 0.000 description 2
- SLLMHZXMVHNZOR-UHFFFAOYSA-N Kakuol Chemical compound C1=C(O)C(C(=O)CC)=CC2=C1OCO2 SLLMHZXMVHNZOR-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241001250596 Pleione Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- WZRCQWQRFZITDX-UHFFFAOYSA-N (RS)-norcoclaurine Chemical compound C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-UHFFFAOYSA-N 0.000 description 1
- 241000563984 Ampelopsis Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241001655727 Celastrus orbiculatus Species 0.000 description 1
- 241000334161 Cercis chinensis Species 0.000 description 1
- 241001247438 Chonemorpha Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241001251068 Formica fusca Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000612166 Lysimachia Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- WZRCQWQRFZITDX-AWEZNQCLSA-N Norcoclaurine Natural products C1=CC(O)=CC=C1C[C@H]1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-AWEZNQCLSA-N 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001604597 Pyrestini Species 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000048 adrenergic agonist Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 201000006334 interstitial nephritis Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- BCZFSDNVXODRAJ-JTTNIQEDSA-N lycopodine Chemical compound C1CCN2CCC[C@@H]3[C@H]4C[C@@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-JTTNIQEDSA-N 0.000 description 1
- BCZFSDNVXODRAJ-ZHMBSYLPSA-N lycopodine Natural products C1CCN2CCC[C@@H]3[C@H]4C[C@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-ZHMBSYLPSA-N 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004938 stress stimulation Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗痛风中草药组合物,各中草药原料按重量配比为:五加皮30、八角枫30、伸筋草30、红花20、防风20、白地牛30、楤木白皮30、络石藤15、牛膝20、川断20、川芎20、冰片20、细辛8、盐肤木叶30、川桂枝15、防己15。它治疗费用低,治疗效果好。
Description
技术领域
本发明涉及一种中药组合物,尤其是指一种治疗痛风中草药组合物。
背景技术
痛风是一种难治愈、易复以的代谢性风湿病。痛风的发病机制与嘌呤代谢障碍及尿酸排泄减少密切相关。痛风的临床特点为高尿酸,特征性反复发作的急性关节炎、痛风石、慢性关节炎以及关节畸形,常累及肾脏引起肾性间质性肾炎和尿酸性肾结石。血尿酸增高继而诱发多个组织损伤,急性痛风性关节炎发病急,有来去如风之称。目前,痛风的西药治疗都是对症处理不利于整体治疗,而且西药有诸多的毒副作用和不良反应。我国传统中医药治疗痛风具有独特的优势,临床和实验研究均显示有较好的疗效。如中国专利曾公开了一种“治疗痛风病的中药”(中国,公开号CN1189374A,公开日1998年8月5日),由木通、益母草、车前子、米仁、苍术、黄柏、牛膝等中草药组成。中国专利曾公开了“一种治疗痛风病的中药”(中国,公开号CN1250664A,公开日2000年4月19日),组分与重量百分比含量为:羌活、独活各3.3-5.9%、青风藤、海桐皮、汉防己、秦艽、苍术各4.5-9.8、络石藤5.8-15.6%、土茯苓、车前子各6.9-15.9%、秦皮13.5-23.0%、厚朴4.7-15.4%。中国专利曾公开了一种“治疗痛风病的中药及其冲剂的制备方法”(中国,公开号CN1397322A,公开日2003年2月19日),它的重量比配方为:西红花1-3份,威灵仙10-30份,车前草10-30份,元参10-20份,白蔹10-20分,白英10-20份,炮姜3-8份,仙灵脾3-8份,地骨皮10-20份。中国专利曾公开了一种“治疗痛风的药物及其丸剂的制备方法”(中国,公开号CN1413714A,公开日2003年4月30日),由下述重量配比的原料配制而成:鳄鱼骨10.9,车前草43.5,金钱草43.5,甘草2.1。中国专利曾公开了“一种治疗痛风疾病的中药制剂”(中国,公开号CN1413664A,公开日2003年4月30日),由伸筋草、秦艽、天葵子、秦皮、苍术、紫荆皮、路路通按比例配制而成。中国专利曾公开了一种“治疗痛风的外用中药酒”(中国,公开号CN1562331A,公开日2005年1月12日),1kg 40-65度的酒中配入包括有以下组分及重量的中草药:川乌16-23g、草乌16-23g、红花12-18g、细辛12-18g、羌活12-18g、一枝蒿9-15g。中国专利曾公开了“一种治疗痛风性关节炎的外敷药物及制备方法”(中国,公开号CN1973880A,公开日2007年6月6日),其药物是由下述重量份的原料制成的:秦皮、蚂蚁各90-100克,萆薢、虎杖各45-50克,六轴子、川芎、赤芍各25-30克,桂枝15-20克,甘草6-8克,薄荷油、凡士林适量。中国专利曾公开了一种“治疗痛风的外用药物组合物”(中国,公开号CN101062289A,公开日2007年10月31日),由以下重量配比的原料制成的外用剂型:丽江山慈菇10-30份、金叶子5-15份、披麻草5-15份、黄柏10-30份、白芨10-30份、大黄10-30份、薄荷脑0.5-1.5份。中国专利曾公开了一种“治疗痛风的药物-痛风宁胶囊及其制备方法”(中国,公开号CN101317958A,公开日2008年12月10日),它是以小剂量雷公藤浸膏为主药,配合山慈菇、制黄柏、制苍术、制川乌、制草乌、防己、丹参、泽兰、牛膝等原料,根据中药的不同特性,分别以炮炙,加水提取、煎液浓缩等处理后,与制马钱子、全蝎、土鳖、三七等中草药细粉混合,按比例配制制成胶囊。中国专利曾公开了“一种治疗痛风的外用药物组合物”(中国,公开号CN101337026A,公开日2009年1月7日),是由以下重量配比的原料制成的丽江山慈菇16-68份、七叶莲茎叶16-68份、金叶子16-68份、披麻草16-68份、黄柏16-68份、白及16-68份、大黄16-68份、薄荷脑2-10份。中国专利曾公开了“一种治疗痛风的中药内服胶囊”(中国,公开号CN101461911A,公开日2009年6月24日),土茯苓、生意仁、萆薢、泽泻、车前子、地龙、赤芍、鸡血藤、当归等22种中草药原料经过磨碎、过筛、消毒、浓缩、混合等工序制成胶囊。中国专利曾公开了一种“治疗痛风的中药制剂及其制备方法”(中国,公布号CN101926896A,公布日2010年12月29日),按照重量份计算,该中药是以金钱草1~30份、威灵仙1~20份、石楠藤1~20份、追风伞1~20份、北牛寄奴1~20份、泽泻1~20份和车前草1~10份为原料药制成的。中国专利曾公开了“一种治疗痛风的中草药制剂及其制备方法”(中国,公布号CN101987150A,公布日2011年3月23日),各种中草药的重量百分比为:苍术15-18克、黄柏15-18克、蚕砂12-15克、木瓜10-12克、牛膝6-8克、丹参15-20克、白芍12-15克、桑枝12-15克、灵脂9-12克、延胡素15-20克、路路通15-20克、槟榔10-12克、云苓15-20克、升麻3-5克、甘草3-5克、丹皮3-5克、银花3-5克、枸杞5-8克、夏枯草3-5克、南星4-6克、水500-1500克。中国专利曾公开了“一种治疗痛风的中药组方”(中国,公布号CN102114204A,公布日2011年7月6日),原料药按下述重量为:土茯苓20-30克,薏苡仁20-30克,虎杖15-25克,蒲公英10-20克,泽泻10-20克,萆薢10-20克,赤芍5-15克,桃仁5-15克,黄柏5-15克和山慈菇5-15克。中国专利曾公开了“一种治疗痛风的中药”(中国,公布号CN102327449A,公布日2012年1月25日),它是由下述重量配比的原料制成:葛根10~20、绞股蓝20~40、女贞子10~20、虫草菌30~50、肉桂15~25、木瓜30~50、当归10~20、知母15~25、红花5~15、白芍20~40、车前子3~10、天葵子5~10、金钱草15~25、山栀10~20、青风藤5~10、板蓝根5~15、蚕砂10~20、络石藤5~10、鸡血藤5~18、丹参10~20、熟地5~15、威灵仙10~20、五灵脂10~20。中国专利曾公开了一种“治疗痛风的中草药制剂”(中国,公布号CN102397418A,公布日2012年4月4日),是由以下重量份的药物制成:防风20-30份;羌活20-30份;川芎25-35份;白附子10-20份;独活20-30份;红蛇根20-40份;南蛇藤10-30份;鹿角藤10-30份;白花臭草6-12份;铜锤玉带草10-30份。
发明内容
本发明的目的在于提供一种治疗痛风中草药组合物,治疗费用低,治疗效果好。
为达到上述目的,本发明采取如下的技术方案:一种治疗痛风中草药组合物,各中草药原料按重量配比为:五加皮30、八角枫30、伸筋草30、红花20、防风20、白地牛30、楤木白皮30、络石藤15、牛膝20、川断20、川芎20、冰片20、细辛8、盐肤木叶30、川桂枝15、防己15。
本发明是在祖传方剂的基础上,根据临床实践,对患者的用药跟踪观察,不断调整配方,形成上述成方。本发明依据传统中医理论及临床经验,组分新颖,配伍得宜,药源广泛,制作简易,对治疗痛风病有明显效果。
具体实施方式
一种治疗痛风中草药组合物,各中草药原料配比为:五加皮30g、八角枫30g、伸筋草30g、红花20g、防风20g、白地牛30g、楤木白皮30g、络石藤15g、牛膝20g、川断20g、川芎20g、冰片20g、细辛8g、盐肤木叶30g、川桂枝15g、防己15g。
各中草药经科学配伍,制成药饼药膏,外敷于患处。可以制成胶囊内服,外敷内服相结合,充分发挥它们的药效。它们的药理作用简述如下。
五加皮:五加皮水煎醇沉或正丁醇提取物有明显抗炎镇痛作用,乙醇浸膏或总皂苻对疲劳,缺氧及高低温等应激刺激有明显保护作用,五加皮多糖能提高机体细胞免疫,总皂苷可使血清抗体浓度有明显提高,还有性缴素样作用,能促进副性腺发育,提取物有保肝作用。
八角枫:八角枫含生物喊、糖苷、酚类气基酚,有机酚、强心苻树脂等,八角枫支根醇提取液能加强催眼药的作用,煎剂或总生物碱均可兴奋呼吸,但当剂量加大时呼吸停止,对正常实验动物可引起血压下降,长期应用可能对肝、肾功能产生一定影响。
伸筋草:伸筋草水浸剂有解热作用,醇提取液有镇痛作用,能显著延长戊巴比妥纳催眼小鼠的睡眼时间,石松碱对离体大鼠,豚鼠小肠及子宫有兴奋作用,有利尿作用、能增加尿酸排泄,还能解除小儿痉性尿潴留及便秘等。
红花:用于活血通经,散瘀止痛跌打损伤,有扩血管作用,能降低冠状动脉阻力,增加冠状动脉血流量,提高心肌营养性血流量,可以兴奋子宫,小剂量使子宫发生节律性收缩,大剂量使子宫肌痉挛,也能降低血清中胆固醇及甘油三醋等作用。
防风:防风水煎剂有中等强度解热作用,1--2小时最明显,有镇痛作用,具有显著抗炎作用,提高巨噬细胞的吞噬百分率和吞指数,防风新鲜汁绿脓杆菌,金黄色葡萄球菌有抑制作用。此外,防风具有抗惊厥作用。
白地牛:用于祛风止痛、脚气水肿、风湿痹痛,湿疹疮毒,对甲醛性关节有抗炎的作用,对骨髓肌有一定的松弛作用,还有降血压、抗过敏、抗癌、镇静、抗菌等作用。楤木白皮:药理:用于祛风除湿,活血上痛、利尿消肿,风湿性关节炎,腰腿疼痛、跌打损伤、痛风等作用。
络石藤:用于祛风通络、凉血消肿、风湿痹痛、筋脉拘挛、腰膝酸痛、跌打损伤,对金黄色葡萄球菌、福氏痢疾杆菌及伤寒杆菌有抑制用,可引起血管,扩张、血压下降等作用。
牛膝:牛膝醇提取具有增强衰竭心脏功能,降低压和兴奋呼吸作用,能降低全血黏度,血细胞比容、红细胞聚集指数,延长凝血酶原时间和血浆复钙时间,牛膝多糖有免疫调节作用和抗肿瘤作用,并有较强的蛋白合成促进作用,牛膝总苷对受孕和末孕子宫有兴奋作用,牛膝总皂苷有明显的抗生育作用,此外,牛膝有抗炎消肿和镇痛功效,还具有抗衰老作用。
川断:续断浸膏和总生物碱对冷血动物和温动物的在体或离体心脏均有明显的正性肌力肌力作用,所含总黄酮能显著降低动脉压和平滑肌的紧张度,总皂苷有降低动脉压的作用。
川芎:川芎嗪能扩张冠状动脉,增加冠状动脉流量、改善心肌的血氧供应,并降低心肌的耗氧量,川芎和川芎嗪在体外对血小扳聚集有显著的抑制作用,并可使聚集的血小扳讯速解聚,具陌防血栓形成的作用,川芎嗪还有抗肿瘤和抗放射作用,水煎剂对动物中枢神经系统有镇痛作用,并有明显的降压作用。
冰片:冰片有明显镇痛和镇静抑菌作用、抗炎作用,合成冰片和然冰片的抑菌作用相同,龙脑、异龙脑均有抗菌作用,并均能显著抑制大鼠蛋清性足跖肿胀,异龙脑对巴豆油耳廓肿胀亦有抑制作用,冰片可作为抗生育药应用,龙脑和异龙脑均能延长小鼠的耐缺氧时间。
细辛:细辛挥发油有解热、镇痛、抗炎和抗惊厥作用,细辛油对细胞免疫及体液都有明显的抑制和抗菌作用,有局部麻醉作用,5%细辛煎剂麻醉,细辛挥发对组胺或乙酰胆所致的气管平滑肌痉挛有非常显著的作用。从细辛中分离出的消旋去甲乌药碱具有肾上腺素能兴奋剂样的广泛生理作用,细辛醇浸剂、挥发油对革兰阳性菌、伤寒杆菌及真菌有抑制作用。
盐肤木叶:用于清热解青、止痛、散瘀、敛肺降火作用,还能治自汗、盗汗、外伤出血不止、遗精、痔疮出血、角毒敛疮,也可用于支气管炎、跌打损伤等作用。
川桂枝:桂枝醇提取物对金黄色葡萄球菌,肺炎杆菌、大肠杆菌,桂枝水煎液对流感病毒亚甲京科68--1株和孤儿病毒亦有抑制作用,桂枝水煎剂和桂皮醛有解热镇痛作用,该作用与扩张外周血管、促进发汗,散热有关桂皮醛有镇静,抗炎和抗惊厥作用,桂皮醛在体对血小板聚集有抑制作用,并有抗凝血酶作用。
防己:药理:用于祛风止痛,风湿痹痛、湿疹疮毒,对甲醛性关节炎有一定程度的抗炎作用,有抗过敏介质的桔抗剂,对骨骼肌有一定的松弛作用还有降血压、抗癌、镇静、抗菌等作用。
该药治疗患者105例,男姓患者73例,女姓患者32例,坚持不住的患者有68例,坚持治疗的患者有37例,重的患者大约二个月至三个月治愈,坚持治疗的患者,治愈可达100%。
Claims (1)
1.一种治疗痛风中草药组合物,其特征在于各中草药原料按重量配比为:五加皮30、八角枫30、伸筋草30、红花20、防风20、白地牛30、楤木白皮30、络石藤15、牛膝20、川断20、川芎20、冰片20、细辛8、盐肤木叶30、川桂枝15、防己15。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210120836.6A CN102626443B (zh) | 2012-04-10 | 2012-04-10 | 治疗痛风中草药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210120836.6A CN102626443B (zh) | 2012-04-10 | 2012-04-10 | 治疗痛风中草药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102626443A true CN102626443A (zh) | 2012-08-08 |
CN102626443B CN102626443B (zh) | 2014-08-06 |
Family
ID=46584951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210120836.6A Expired - Fee Related CN102626443B (zh) | 2012-04-10 | 2012-04-10 | 治疗痛风中草药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102626443B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211976A (zh) * | 2013-05-03 | 2013-07-24 | 蔡光正 | 一种治疗痛风的外用中药制剂 |
CN104622978A (zh) * | 2015-03-15 | 2015-05-20 | 侯苏 | 一种在内科房间用于治疗痛风的药剂 |
CN107184595A (zh) * | 2017-06-14 | 2017-09-22 | 成都中医药大学 | 川牛膝多糖在制备痛风的药物中的用途 |
CN107714987A (zh) * | 2017-11-27 | 2018-02-23 | 安徽恒海生态农业观光园有限公司 | 一种除痹除湿的中草药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1146343A (zh) * | 1995-09-25 | 1997-04-02 | 石建民 | 一种治疗椎间盘病的外敷膏 |
CN101244252A (zh) * | 2008-03-13 | 2008-08-20 | 张金星 | 一种消除疼痛的中药药贴及其制备方法 |
-
2012
- 2012-04-10 CN CN201210120836.6A patent/CN102626443B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1146343A (zh) * | 1995-09-25 | 1997-04-02 | 石建民 | 一种治疗椎间盘病的外敷膏 |
CN101244252A (zh) * | 2008-03-13 | 2008-08-20 | 张金星 | 一种消除疼痛的中药药贴及其制备方法 |
Non-Patent Citations (3)
Title |
---|
姚共和等: "中医期刊治疗膝关节骨关节炎方剂用药特点分析", 《湖南中医学院学报》 * |
张廷伟: "中医药治疗痛风性关节炎近况", 《江西中医药》 * |
王永达: "运用中草药治疗腰椎间盘突出症52例小结", 《中医正骨》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211976A (zh) * | 2013-05-03 | 2013-07-24 | 蔡光正 | 一种治疗痛风的外用中药制剂 |
CN104622978A (zh) * | 2015-03-15 | 2015-05-20 | 侯苏 | 一种在内科房间用于治疗痛风的药剂 |
CN107184595A (zh) * | 2017-06-14 | 2017-09-22 | 成都中医药大学 | 川牛膝多糖在制备痛风的药物中的用途 |
CN107714987A (zh) * | 2017-11-27 | 2018-02-23 | 安徽恒海生态农业观光园有限公司 | 一种除痹除湿的中草药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102626443B (zh) | 2014-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101926900B (zh) | 一种足浴组合物及其制备方法 | |
CN1742939B (zh) | 一种治疗肺间质纤维化的药物及其制备方法 | |
CN103784820B (zh) | 用于治疗心血瘀阻型冠心病的中药配方及中药胶囊 | |
CN103860699B (zh) | 一种用于根治三高的药物组合物 | |
CN102302563A (zh) | 一种治疗慢性肾功能衰竭的中药组合物及其制备方法 | |
CN102106974A (zh) | 偏瘫康复口服液 | |
CN103386022B (zh) | 一种治疗结核性胸膜炎的中药组合物 | |
CN108478731A (zh) | 用于治疗心血瘀阻型冠心病的中药配方及中药胶囊 | |
CN102626443B (zh) | 治疗痛风中草药组合物 | |
CN102626478A (zh) | 治疗陈年腰肌劳损外用中草药组合物 | |
CN101912596B (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
CN100566735C (zh) | 一种治疗急慢性肺炎的药物组合物及其制备方法和用途 | |
CN102614470B (zh) | 治疗中风后遗症外用中草药组合物 | |
CN102626477B (zh) | 治疗陈年跌打损伤外用中草药组合物 | |
CN101987135B (zh) | 一种治疗破伤风的药物及其制备方法 | |
CN101912498B (zh) | 一种治疗痛风的药物及其制备方法 | |
CN101156922A (zh) | 一种归肝、肾经治疗失眠的中药组合物 | |
CN102366597A (zh) | 防治神经抑郁症的中药制剂 | |
CN112691157A (zh) | 一种风湿类关节炎药材组合物的配方及制备方法 | |
CN105561272A (zh) | 一种用于缓解雷诺病的中药制剂及其制备方法 | |
CN101549140B (zh) | 治疗艾滋病的中药组合物及其制备方法 | |
CN110384785A (zh) | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 | |
CN103816399A (zh) | 一种用于治疗犬瘟热病的中药制剂 | |
CN108704064A (zh) | 一种治疗艾滋病的中药组合物和制备方法 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140806 |
|
CF01 | Termination of patent right due to non-payment of annual fee |